Cargando…

Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients

The association between estrogen‐containing oral contraceptives and history of pregnancies with disease severity in women with polycystic liver disease (PLD) is unclear. We performed a cross‐sectional cohort study to assess this association by selecting female patients with PLD of which imaging was...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Aerts, René M.M., Bernts, Lucas H.P., Gevers, Tom J.G., Kievit, Wietske, Koopmans, Lisanne, Nieboer, Theodoor E., Nevens, Frederik, Drenth, Joost P.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896230/ https://www.ncbi.nlm.nih.gov/pubmed/31206615 http://dx.doi.org/10.1002/cpt.1553

Ejemplares similares

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
por: van Aerts, René M. M., et al.
Publicado: (2018)

Impact of liver volume on polycystic liver disease-related symptoms and quality of life
por: Neijenhuis, Myrte K, et al.
Publicado: (2017)

Tamoxifen for the treatment of polycystic liver disease: A case report
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
por: Gevers, Tom JG, et al.
Publicado: (2012)

Estrogens in polycystic liver disease: A target for future therapies?
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis
por: Bernts, Lucas H. P., et al.
Publicado: (2018)

Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life
por: Duijzer, Renée, et al.
Publicado: (2022)

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression
por: Neijenhuis, Myrte K., et al.
Publicado: (2017)

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial
por: Wijnands, Titus FM, et al.
Publicado: (2015)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

Contraceptive Use in Premenopausal Women With Early Breast Cancer
por: Lambertini, Matteo, et al.
Publicado: (2022)

Oral contraceptive use and risk of melanoma in premenopausal women
por: Feskanich, D, et al.
Publicado: (1999)

Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series
por: Bernts, Lucas H P, et al.
Publicado: (2020)

Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
por: Pape, Simon, et al.
Publicado: (2020)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Cost-effectiveness of a new strategy to identify uncomplicated gallstone disease patients that will benefit from a cholecystectomy
por: Lamberts, Mark P., et al.
Publicado: (2016)

Protocol for a randomized controlled multicenter trial assessing the efficacy of leuprorelin for severe polycystic liver disease: the AGAINST-PLD study
por: Aapkes, S. E., et al.
Publicado: (2022)

Urinary Estrogen Metabolites in 2 Soy Trials with Premenopausal Women
por: Maskarinec, Gertraud, et al.
Publicado: (2012)

Ethanol sclerotherapy or polidocanol sclerotherapy for symptomatic hepatic cysts
por: Wijnands, Titus FM, et al.
Publicado: (2018)

Effects of hormonal contraceptives on sleep - A possible treatment for insomnia in premenopausal women
por: Bezerra, Andreia Gomes, et al.
Publicado: (2018)

Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women
por: Frydenberg, Hanne, et al.
Publicado: (2015)

Menstrual Cycle Phase, Hormonal Contraception, and Alcohol Consumption in Premenopausal Females: A Systematic Review
por: Warren, Jasmine G., et al.
Publicado: (2021)

The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women
por: Williams, Andrew E, et al.
Publicado: (2002)

Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease
por: Janssen, Manoe J., et al.
Publicado: (2012)

Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy
por: Aapkes, Sophie E., et al.
Publicado: (2023)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Effects of orally administered hormonal contraceptives on the musculoskeletal system of healthy premenopausal women—A systematic review
por: Römer, Claudia, et al.
Publicado: (2022)

Episodic Abdominal Pain Characteristics Are Not Associated with Clinically Relevant Improvement of Health Status After Cholecystectomy
por: Lamberts, Mark P., et al.
Publicado: (2016)

Different Effects of Oral Contraceptive and Dydrogesterone Treatment on Oxidative Stress Levels in Premenopausal Women
por: Chen, Jui-Tung, et al.
Publicado: (2018)

Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis
por: Silva-Bermudez, Lina S, et al.
Publicado: (2020)

Broad Metabolome Alterations Associated with the Intake of Oral Contraceptives Are Mediated by Cortisol in Premenopausal Women
por: Eick, Clara, et al.
Publicado: (2021)

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis
por: Fabunmi, Oyesanmi A., et al.
Publicado: (2023)

Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women
por: Iversen, Anita, et al.
Publicado: (2016)

Gastroparesis in patients with inactive Crohn's disease: a case series
por: Kristinsson, Jón O, et al.
Publicado: (2007)

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

Bone health in estrogen-free contraception
por: Hadji, P., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jgu89b1t58i5f1t8d0071t1kna